An Empiric Risk Scoring Tool for Identifying High-Risk Heterosexual HIV-1―Serodiscordant Couples for Targeted HIV-1 PreventionKAHLE, Erin M; HUGHES, James P; BAETEN, Jared M et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 3, pp 339-347, issn 1525-4135, 9 p.Article

Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countriesMCDOUGAL, J. Steven; PILCHER, Christopher D; PAREKH, Bharat S et al.AIDS (Supplement). 2005, Vol 19, pp S25-S30, issn 1350-2840, SUP2Article

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccinesGIL, Cristina; CLIMENT, Nuria; PUMAROLA, Tomas et al.Vaccine. 2011, Vol 29, Num 34, pp 5711-5724, issn 0264-410X, 14 p.Article

Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq^™ 2.0 and an in-house methodSARAVANAN, S; VIDYA, M; BALAKRISHANAN, P et al.Journal of virological methods. 2009, Vol 159, Num 2, pp 211-216, issn 0166-0934, 6 p.Article

Quantitative detection of HIV-1 RNA using NucliSens EasyQ HIV-1 assayJUN YAO; ZHEN LIU; KO, Lung-Sang et al.Journal of virological methods. 2005, Vol 129, Num 1, pp 40-46, issn 0166-0934, 7 p.Article

Impact of HIV-1 Genetic Diversity in China on the Measurement of Viral LoadYOUCHUN WANG; AIJING SONG; SIHONG XU et al.Journal of medical virology. 2008, Vol 80, Num 1, pp 1-8, issn 0146-6615, 8 p.Article

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 InfectionLEWIN, Sharon R; MURRAY, John M; COOPER, David A et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 2, pp 140-147, issn 1525-4135, 8 p.Article

Transition From Long-Term Nonprogression to HIV-1 Disease Associated With Escape From Cellular Immune ControlSHEREFA KEMAL, Kimdar; BEATTIE, Tara; COLLMAN, Ronald et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 2, pp 119-126, issn 1525-4135, 8 p.Article

Fighting a virus with a virus: a dynamic model for HIV-1 therapyREVILLA, Tomas; GARCIA-RAMOS, Gisela.Mathematical biosciences. 2003, Vol 185, Num 2, pp 191-203, issn 0025-5564, 13 p.Article

Identification of amino acid residues in HIV-1 Vif critical for binding and exclusion of APOBEC3G/FYAMASHITA, Tomoki; KAMADA, Kazuya; HATCHO, Kazuki et al.Microbes and infection. 2008, Vol 10, Num 10-11, pp 1142-1149, issn 1286-4579, 8 p.Article

Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivityYAMASHITA, Tomoki; NOMAGUCHI, Masako; MIYAKE, Ariko et al.Microbes and infection. 2010, Vol 12, Num 2, pp 166-171, issn 1286-4579, 6 p.Article

Inhibitory effect of human TRIM5α on HIV-1 productionXIANFENG ZHANG; KONDO, Mariko; JING CHEN et al.Microbes and infection. 2010, Vol 12, Num 10, pp 768-777, issn 1286-4579, 10 p.Article

Evasion from CypA-and APOBEC-mediated restrictions is insufficient for HIV-1 to efficiently grow in simian cellsKAMADA, Kazuya; YAMASHITA, Tomoki; HATCHO, Kazuki et al.Microbes and infection. 2009, Vol 11, Num 2, pp 164-171, issn 1286-4579, 8 p.Article

Novel biocompatible anionic polymeric microspheres for the delivery of the HIV- 1 Tat protein for vaccine applicationCAPUTO, Antonella; BROCCA-COFANO, Egidio; DOMINICI, Sabrina et al.Vaccine. 2004, Vol 22, Num 21-22, pp 2910-2924, issn 0264-410X, 15 p.Article

Evaluation of the QIAsymphony^™ SP and Artus^™ RealTime extraction-quantification systems for measuring HIV-1 virus loadSANDRES-SAUNE, K; RAYMOND, S; NICOT, F et al.Journal of clinical virology. 2011, Vol 52, Num 4, pp 349-352, issn 1386-6532, 4 p.Article

Structural Effects of Amino Acid Variations Between B and CRF02-AG HIV-1 IntegrasesMALET, Isabelle; SOULIE, Cathia; MARCELIN, Anne-Geneviève et al.Journal of medical virology. 2008, Vol 80, Num 5, pp 754-761, issn 0146-6615, 8 p.Article

Role of HIV-1 Vpu protein for virus spread and pathogenesisNOMAGUCHI, Masako; FUJITA, Mikako; ADACHI, Akio et al.Microbes and infection. 2008, Vol 10, Num 9, pp 960-967, issn 1286-4579, 8 p.Article

Construction of gag-chimeric viruses between HIV-1 and SIVmac that are capable of productive multi-cycle infectionKAMADA, Kazuya; YOSHIDA, Akiko; KHAMSRI, Boonruang et al.Microbes and infection. 2006, Vol 8, Num 4, pp 1075-1081, issn 1286-4579, 7 p.Article

Increased frequency of viral loads above 100000 HIV-1 RNA copies/ml measured by Roche Cobas TaqMan assay in comparison with Cobas Amplicor assayGRGIC, Ivana; LEPEJ, Snjezana Zidovec; VINCE, Adriana et al.Journal of clinical virology. 2010, Vol 48, Num 1, pp 75-76, issn 1386-6532, 2 p.Article

Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimerNKOLOLA, Joseph P; CHEUNG, Ann; PERRY, James R et al.Vaccine. 2014, Vol 32, Num 18, pp 2109-2116, issn 0264-410X, 8 p.Article

APOBEC3G/F as one possible driving force for co-receptor switch of the human immunodeficiency virus-1HEGER, Eva; THIELEN, Alexander; GILLES, Ramona et al.Medical microbiology and immunology. 2012, Vol 201, Num 1, pp 7-16, issn 0300-8584, 10 p.Article

Advances in developing HIV-1 viral load assays for resource-limited settingsSHUQI WANG; FENG XU; DEMIRCI, Utkan et al.Biotechnology advances. 2010, Vol 28, Num 6, pp 770-781, issn 0734-9750, 12 p.Article

Design and characterization of an HIV-1 Tat mutant : Inactivation of viral and cellular functions but not antigenicityMAYOL, Katia; MUNIER, Séverine; BECK, Alain et al.Vaccine. 2007, Vol 25, Num 32, pp 6047-6060, issn 0264-410X, 14 p.Article

Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formationKUMAR, Rajnish; TUEN, Michael; HUALIN LI et al.Vaccine. 2011, Vol 29, Num 48, pp 9064-9074, issn 0264-410X, 11 p.Article

Extraction buffer contaminated bacterially as a cause of invalid HIV-1 viral load results on the NucliSens Easyo® systemCLAASSEN, M; VAN ZYL, G. U; PREISER, W et al.Journal of virological methods. 2008, Vol 150, Num 1-2, pp 80-81, issn 0166-0934, 2 p.Article